Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H17NO3 |
| Molecular Weight | 223.2683 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCOCCOC(=O)C1=CC=CN=C1
InChI
InChIKey=IZJRISIINLJVBU-UHFFFAOYSA-N
InChI=1S/C12H17NO3/c1-2-3-7-15-8-9-16-12(14)11-5-4-6-13-10-11/h4-6,10H,2-3,7-9H2,1H3
| Molecular Formula | C12H17NO3 |
| Molecular Weight | 223.2683 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://gp2u.com.au/static/pdf/F/FINALGON-PI.pdfCurator's Comment: for description additional reference was used http://onlinelibrary.wiley.com/doi/10.1002/ejp.719/full
Sources: https://gp2u.com.au/static/pdf/F/FINALGON-PI.pdf
Curator's Comment: for description additional reference was used http://onlinelibrary.wiley.com/doi/10.1002/ejp.719/full
Nicoboxil is a nicotinate used in topical preparations as a rubefacient which has vasodilating properties mediated by
prostaglandin. Nicoboxil is a component of finalgon® (nonivamid and nicoboxil), a topical cream for joint and muscle pains. The hyperaemic effect of Nicoboxil has an earlier onset and it is more intense than the nonivamide hyperaemic effect.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0045909 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Finalgon Approved UseNicobaxol as a component of Finalgon is used for the temporary relief of the pain of rheumatism, arthritis, lumbago, muscular aches, sprains and strains, sporting injuries and other conditions where local warmth is beneficial. Launch Date1994 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Topical application of cream containing nonivamide and nicoboxil does not enhance the performance of experienced cyclists during a 4-km time-trial. | 2016-05 |
|
| Efficacy and safety of nicoboxil/nonivamide ointment for the treatment of acute pain in the low back - A randomized, controlled trial. | 2016-02 |
|
| Evaluation of changes in the haemoglobin of skin and muscle tissue of the calf, as induced by topical application of a nonivamide/nicoboxil cream. | 2014-02 |
|
| A comparison of pretreatment with a topical combination of nonivamide and nicoboxil and surgical delay in a random pattern skin flap model. | 2009-07 |
|
| Improved dorsal random-pattern skin flap survival in rats with a topically applied combination of nonivamide and nicoboxil. | 2003-03 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:49:11 GMT 2025
by
admin
on
Mon Mar 31 17:49:11 GMT 2025
|
| Record UNII |
GSD5B9US0W
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C241
Created by
admin on Mon Mar 31 17:49:11 GMT 2025 , Edited by admin on Mon Mar 31 17:49:11 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
GSD5B9US0W
Created by
admin on Mon Mar 31 17:49:11 GMT 2025 , Edited by admin on Mon Mar 31 17:49:11 GMT 2025
|
PRIMARY | |||
|
235788
Created by
admin on Mon Mar 31 17:49:11 GMT 2025 , Edited by admin on Mon Mar 31 17:49:11 GMT 2025
|
PRIMARY | RxNorm | ||
|
DTXSID4057635
Created by
admin on Mon Mar 31 17:49:11 GMT 2025 , Edited by admin on Mon Mar 31 17:49:11 GMT 2025
|
PRIMARY | |||
|
C473307
Created by
admin on Mon Mar 31 17:49:11 GMT 2025 , Edited by admin on Mon Mar 31 17:49:11 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105161
Created by
admin on Mon Mar 31 17:49:11 GMT 2025 , Edited by admin on Mon Mar 31 17:49:11 GMT 2025
|
PRIMARY | |||
|
4757
Created by
admin on Mon Mar 31 17:49:11 GMT 2025 , Edited by admin on Mon Mar 31 17:49:11 GMT 2025
|
PRIMARY | |||
|
SUB09231MIG
Created by
admin on Mon Mar 31 17:49:11 GMT 2025 , Edited by admin on Mon Mar 31 17:49:11 GMT 2025
|
PRIMARY | |||
|
237-684-7
Created by
admin on Mon Mar 31 17:49:11 GMT 2025 , Edited by admin on Mon Mar 31 17:49:11 GMT 2025
|
PRIMARY | |||
|
14866
Created by
admin on Mon Mar 31 17:49:11 GMT 2025 , Edited by admin on Mon Mar 31 17:49:11 GMT 2025
|
PRIMARY | |||
|
DB12911
Created by
admin on Mon Mar 31 17:49:11 GMT 2025 , Edited by admin on Mon Mar 31 17:49:11 GMT 2025
|
PRIMARY | |||
|
C84007
Created by
admin on Mon Mar 31 17:49:11 GMT 2025 , Edited by admin on Mon Mar 31 17:49:11 GMT 2025
|
PRIMARY | |||
|
13912-80-6
Created by
admin on Mon Mar 31 17:49:11 GMT 2025 , Edited by admin on Mon Mar 31 17:49:11 GMT 2025
|
PRIMARY | |||
|
100000084188
Created by
admin on Mon Mar 31 17:49:11 GMT 2025 , Edited by admin on Mon Mar 31 17:49:11 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |